CAD regimen effective in advanced multiple myeloma

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1280, 2001-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thalidomide is effective when added to dexamethasone for the treatment of newly diagnosed multiple myeloma

By  

Inpharma, Vol. 1, Iss. 1527, 2006-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Multiple myeloma

By Samson Diana   Singer Charles  

Clinical Medicine, Vol. 1, Iss. 5, 2001-09 ,pp. : 365-370

Royal College Of Physicians

Access to resources Recommend Favorite

DCEP an alternative to standard regimen in myeloma

By  

Inpharma, Vol. 1, Iss. 1462, 2004-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Bortezomib in multiple myeloma

By Terpos Evangelos   Roussou Maria   Dimopoulos Meletios-Athanassios  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 5, 2008-05 ,pp. : 639-654

Informa Healthcare

Access to resources Recommend Favorite

Breakthroughs in the Management of Multiple Myeloma

By Heffner Jr L.T.   Lonial S.  

Drugs, Vol. 63, Iss. 16, 2003-01 ,pp. : 1621-1636

Adis International

Access to resources Recommend Favorite